The global protein drugs market was valued $xx Mn. in 2019 and is expected to reach $xx Mn in 2027, at
a CAGR of xx%.
Global Protein Drugs Market Introduction and Overview
Protein drugs are artificially synthesized proteins for treatment of chronic diseases such as cancer and
diabetes. They are fast-acting medicines capable of delivering small protein molecules to the body in
specific amount. Protein drugs has become an important segment of the healthcare industry and has a
high demand. Advances in biological sciences have shown a positive impact on the global protein drugs
market. The future of this market is expected to be promising due to rise in prevalence of chronic
diseases, unmet needs for effective treatments and advances in drug development and manufacturing.
Advantages of protein drugs such as their efficiency, efficacy and low toxicity are boosting the market
growth. Factors such as rising R&D activities, increasing pharmaceutical industries, rapid advances in
genetic engineering are the key drivers to the market. Increasing adoption of protein drugs in emerging
economies is expected to grow opportunities for the market in future.
However, high costs of drugs due to expensive procedures and complex approval processes are
restraining the market growth.
The report covers the detailed analysis of global market for protein drugs with the classifications of the
market based on products, applications and region. Analysis of past market dynamics from 2016 to 2019
is given in the report, which will help readers to benchmark the past trends with current market
scenarios with the key players contribution in it.
The report has profiled seventeen key players in the market from different regions. However, report has
considered all market leaders, followers and new entrants with investors while analysing the market and
estimation the size of the same. The growing healthcare infrastructure in each region is different and
focus is given on availability of advanced technology and new techniques. R